Pharmaceutical

Oesophageal cancer: the global clinical trials landscape in 2024

With new oesophageal cancer cases annually projected to increase by 80% before 2050, find out more about current and developing treatments.

Aug 29, 2024 - 04:00
Oesophageal cancer: the global clinical trials landscape in 2024
With new oesophageal cancer cases annually projected to increase by 80% before 2050, find out more about current and developing treatments.
Read the original article

Tags:

Previous Article

Soleno wins FDA priority review for Prader-Willi therapy

Next Article

Navigator gains $100m in Series A funding for antibody therapeutics

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

China NMPA grants IND clearance for Fermion’s TYK2 JH2 inhibitor

China NMPA grants IND clearance for Fermion’s TYK2 JH2 ...

Feb 6, 2024

STAT+: Why Novartis is going to walk away from its acquisition of MorphoSys

STAT+: Why Novartis is going to walk away from its acqu...

Feb 7, 2024

Telix adds another trial in its targeted radiation therapy development programme

Telix adds another trial in its targeted radiation ther...

Jul 19, 2023